Please try another search
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical formulations primarily in india. it offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, anti-fungals, anti-ulcerants/antacids, aphrodisiacs, anti-malarials, anthelmintics, and anti- diabetics, as well as consumer products. The company provides its products through stockists and super stockists to doctors, chemists, large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. It also exports its products to approximately 13 countries worldwide. The company was incorporated in 1985 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Dilip Harkisandas Bhuta | 70 | 2013 | CFO & Whole Time Director |
Ashish Uttam Bhuta | 49 | 2007 | Chairman & MD |
Hina Ravindran Mehta | 61 | 2020 | Non-Executive Independent Director |
Sumit Ajaybhai Thakkar | 41 | 2023 | Non-Executive Independent Director |
Krishnan Subharaman | 63 | 2024 | Additional Non-Executive Independent Director |
Pankaj Dantwala | 65 | 2024 | Additional Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review